Evidence map›Paper›PMID 36559019›Full record

ArticlePharmaceuticals (Basel, Switzerland)2022

Component Characterization, In Vitro Activities and Molecular Mechanism of

Bingqing Chi, Xilong Liang, Lihua Wang, Yifei Bian, Meng Zhang, Zhixin Tang, Danyang Wang, Zhenhua Tian

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Bingqing ChiCollege of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.
Xilong LiangDepartment of Biostatistics, School of Public Health, Yale University, New Haven, CT 06489, USA.
Lihua WangInnovation Institute of Chinese Medicine and Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.
Yifei BianInnovation Institute of Chinese Medicine and Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.
Meng ZhangExperimental Center, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.
Zhixin TangExperimental Center, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.
Danyang WangInnovation Institute of Chinese Medicine and Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.ORCID 0000-0003-3471-4231
Zhenhua TianCollege of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.ORCID 0000-0002-7244-9822
Shandong University of Traditional Chinese Medicine · CNYale University · US

Funding

Shandong Province Traditional Chinese Medicine Science and Technology Development Plan 2019-0019, 2019-0021the National Natural Science Foundation of China 81774173
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antioxidant activitycomponent characterizationCydonia oblonga Mill.diabeticα-glucosidase inhibitory activity

Identifiers

PMID36559019
PMCPMC9783571
OpenAlexW4312195245

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.